Global cancer cases and deaths expected to soar by 2050 despite advances in treatment
View as a Web Page
News Medical
 
  Breast Cancer Breast Cancer logo  
  The latest breast cancer news from News Medical  
 Molecular breast imaging increases overall invasive cancer detection in women with dense breastsMolecular breast imaging increases overall invasive cancer detection in women with dense breasts
 
Screening women with dense breasts with both molecular breast imaging (MBI) and digital breast tomosynthesis (DBT) increased overall invasive cancer detection while modestly increasing the recall rate compared with screening only with DBT, according to a new study published today in Radiology, a journal of the Radiological Society of North America.
 
 
 Global cancer cases and deaths expected to soar by 2050 despite advances in treatmentGlobal cancer cases and deaths expected to soar by 2050 despite advances in treatment
 
There has been a rapid increase in the global number of cancer cases and deaths between 1990 and 2023, despite advances in cancer treatment and efforts to tackle cancer risk factors over that same time period.
 
   New PET tracer enables rapid imaging of aggressive breast and bladder cancersNew PET tracer enables rapid imaging of aggressive breast and bladder cancers
 
A promising new PET tracer can visualize a protein that is commonly overexpressed in triple-negative breast and urothelial bladder cancers within four hours, according to new research published in the September issue of The Journal of Nuclear Medicine.
 
   Regular mammograms linked to longer survival in women over 80Regular mammograms linked to longer survival in women over 80
 
For many older women, the question of whether to continue breast cancer screening has been uncertain. While most guidelines recommend mammograms up to age 74, advice for women 75 and older has been less clear.
 
   Sylvester part of major national study on AI use in breast cancer screeningSylvester part of major national study on AI use in breast cancer screening
 
Sylvester Comprehensive Cancer Center, part of University of Miami Miller School of Medicine, will co-lead a newly funded, multi-institutional clinical trial to evaluate whether artificial intelligence (AI) can help support radiologists in interpreting mammograms more accurately, with the goal of improving breast cancer screening and reducing unnecessary callbacks and anxiety for patients.
 
 Missing the first mammogram raises risk of advanced breast cancer
 
Missing the first mammogram raises risk of advanced breast cancerWomen who miss their first mammogram run a higher risk of being diagnosed with advanced breast cancer and dying from the disease.
 
 
 Severe obesity linked to lower rates of recommended cancer screenings
 
Severe obesity linked to lower rates of recommended cancer screeningsIn a recent cross-sectional study, researchers from Pennington Biomedical Research Center found that severe obesity is associated with a lower rate of cancer screenings.
 
 
 Study Uncovers How Cell Clustering Affects Glioblastoma Aggressiveness
 
Study Uncovers How Cell Clustering Affects Glioblastoma AggressivenessA new study, led by researchers at Sylvester Comprehensive Cancer Center part of the University of Miami Miller School of Medicine, captured details of glioblastoma that had never before been seen and revealed a surprise finding: Glioblastoma cells that "cluster" together with other cells of the same type are less deadly than those that disperse from these clusters.
 
 
 IGF2BP3 protein drives leukemia growth by linking metabolism and RNA control
 
Cancer cells are relentless in their quest to grow and divide, often rewiring their metabolism and modifying RNA to stay one step ahead.
 
 
 UCLA presents advances in radiation therapy at ASTRO 2025
 
Physicians and scientists from the UCLA Health Jonsson Comprehensive Cancer Center will share the latest research and clinical trial results at the 2025 American Society for Radiation Oncology (ASTRO) Annual Meeting, including studies on targeted radioactive therapy for recurrent prostate cancer, new approaches to stereotactic body radiation for prostate and head and neck cancers, advances in MRI- and 5DCT-guided imaging for more precise...
 
 
 UCLA to co-lead a large-scale randomized trial of AI in breast cancer screening
 
UCLA and UC Davis will co-lead a newly funded, multi-institutional clinical trial to evaluate whether artificial intelligence (AI) can help support radiologists in interpreting mammograms more accurately, with the goal of improving breast cancer screening and reducing unnecessary callbacks and anxiety for patients.
 
Facebook X Instagram LinkedIn Vimeo
Why did you receive this email?
You are receiving this email because you subscribed to updates from AZoNetwork UK Ltd. on one of our websites and requested to be notified of additional information.

Unsubscribe or Update Notification Preferences

Contact | About | Privacy Policy

- - - - - -

Registered Address:
AZoNetwork UK Ltd., NEO, 9 Charlotte St, Manchester, M1 4ET, UK

Manchester | Sydney | Boston

Copyright © 2000-2025